Skip to main content
OpenTrials
Completed

NCT Number: NCT05513378

Ultrasound-guided Subclavian Vein Catheterisation With a Needle Guide

OBJECTIVES The primary objective is to compare if the addition of a needle guide can reduce the number of central venous catheter (CVC) insertions with >1 skin puncture in ultrasound-guided catheterization of the subclavian vein using the long-axis approach with an in-plane needling technique.

Secondary objectives include if this addition 1) decreases the frequency of mechanical complications (defined as bleeding, arterial puncture, arterial catheterization, nerve injury, pneumothorax), 2) increases the time when the needle is visible, 3) decreases the time until successful vessel punction, 4) decreases the number of needle redirections during the insertion, and 5) a comparison between the two groups regarding number of failed catheterizations.

DESIGN This is a prospective, randomised, controlled, parallel intervention study. Patients will be enrolled at Skåne University Hospital in Lund, Sweden. The trial is investigator-initiated and non-commercial.

POPULATION AND INTERVENTION Adults (18 years of age or older) in need of a subclavian CVC for any reason and able to give written informed consent will be included in the study provided no exclusion criteria is fulfilled.

OUTCOMES Primary outcome will be number of CVC insertions with >1 skin puncture. Secondary outcomes include comparison between the two groups regarding 1) the frequency of mechanical complications, 2) proportion of the insertion-time when the needle is visible on the ultrasound (US) screen, 3) time to successful vessel punction, 4) the number of needle redirections during the insertion, 5) number of failed catheterisations, 6) Feasibility of the needle guide evaluated with a questionair to the operators at the end of the study.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–105 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Intensive and Perioperative Care. Skåne University Hospital. Lund

Lund, Skåne County, 22185, Sweden

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients in need of a central venous catheter .
  • Clinical indication for the subclavian route which includes expected time of use >5 days.
  • Signed informed consent.

Exclusion criteria

  • Patient is deemed unsuitable for cannulation of the subclavian vein, based on a pre-procedural US examination by the operator, or due to unacceptable patient risk in case of mechanical complication (e.g., severe respiratory failure).

Treatment and study plan

Needle guide

Device

Please see the arm/group description

Other names: The Ultra-Pro II™ Needle Guide, model C8-5 Philips

Primary outcomes

  1. Number of subclavian catheter insertions with >1 skin puncture

    Time frame: During the central venous catheterization, up to 3 hours after inclusion

    Number of subclavian catheter insertions with >1 skin puncture

Secondary outcomes

  1. The frequency of mechanical complications

    Time frame: 24 hours after the completion of the central venous catheterization

    Mechanical complication include: 1) Bleeding World Health Organization (WHO)-grade 2-4. 2) Pneumothorax visible on post-procedural Xray. 3) Permanent nerve injury. 4) Arrhythmia WHO-grade 3 and 4. 5) Arterial catheterization

  2. Needle visibility

    Time frame: During the central venous catheterization, up to 4 hours after inclusion

    Proportion of the insertion-time when the needle is visible on the ultrasound screen

  3. Time to successful vessel puncture

    Time frame: During the central venous catheterization, up to 4 hours after inclusion

    Time to successful vessel puncture

  4. The number of needle redirections

    Time frame: During the central venous catheterization, up to 4 hours after inclusion

    The number of needle redirections during the insertion

  5. The number of failed catheterizations

    Time frame: During the central venous catheterization, up to 4 hours after inclusion

    The number of failed catheterizations in the attempted subclavian vein

  6. Feasibility of the needle guide

    Time frame: Through the study period, anticipated 3 years

    Feasibility of the needle guide by means of a questionnaire at the end of the study period.

Sponsors and collaborators

Lead sponsor

Thomas Kander

Other

Registry information

Official study title

A Randomized Controlled Trial Comparing In-line Ultrasound Guided Subclavian Vein Catheterization With or Without Needle Guide.

Acronym: ELUSIVE

Important dates

Study start
2022
Primary completion
2025
Study completion
2025
First posted
Aug 24, 2022
Registry last updated
Oct 6, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.